Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01295346 · ClinicalTrials.gov registry record
Biomarkers of Mild and Moderate Traumatic Brain Injury
A clinical trial, sponsored by Banyan Biomarkers.
- Completed
- Registry status
- 290
- Enrollment target
NCT01295346: Completed study, sponsored by Banyan Biomarkers.
NCT01295346 is a clinical trial that has completed, run by Banyan Biomarkers. The registered enrollment target is 290 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01295346 has completed, sponsored by Banyan Biomarkers.
- COMPLETED
- Registry status
- 290 participants
- Enrollment target
Study Summary
The purpose of this study is to assess if putative brain injury biomarkers have utility as blood-based traumatic brain injury (TBI) diagnostic and monitoring tools. This will be accomplished by examining the relationships between potential serum-based TBI biomarkers and clinical measures of injury severity, occurrence of complications, and outcome, in subjects with mild or moderate TBI. The assay will be evaluated in a sample population of subjects over the age of 18 who have been referred to the health care provider for closed head injury evaluation.
Interventions
- OTHER Head CT scan and blood draw
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 290 participants |
| Start Date | 2011-01 |
| Est. Completion | 2012-03 |
What the finished NCT01295346 record still lists
NCT01295346 is an observational study that tracks outcomes without assigning an intervention. The registered 290 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Head CT scan and blood draw is the first listed.
NCT01295346 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01295346 about?
NCT01295346 is a clinical study titled "Biomarkers of Mild and Moderate Traumatic Brain Injury". The purpose of this study is to assess if putative brain injury biomarkers have utility as blood-based traumatic brain injury (TBI) diagnostic and monitoring tools. This will be accomplished by examining the relationships between potential serum-based TBI biomarkers and clinical measures of injury s...
What is the current status of trial NCT01295346?
This trial is currently completed. The enrollment target is 290 participants. The study started on 2011-01. Estimated completion is 2012-03.
What interventions are being tested in trial NCT01295346?
The interventions under investigation include: Head CT scan and blood draw (OTHER).
Who is sponsoring clinical trial NCT01295346?
This trial is sponsored by Banyan Biomarkers, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00775476 · 290 participants · Phase 2
Treatment of Systemic Lupus Erythematosus (SLE) With N-acetylcysteine
- NCT01874197 · 290 participants · NA
Branched Thoracic Endovascular Grafts for the Treatment of Thoraco-abdominal Aortic
- NCT04331353 · 290 participants · NA
The Allergen Reduction and Child Health Study (ARCHS)
- NCT04649008 · 290 participants · Early Phase 1
Localizing Epileptic Networks Using MRI and iEEG
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia